Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer

Condition:   Recurrent Head and Neck Squamous Cell Carcinoma
Interventions:   Radiation: IMRT;   Biological: Nivolumab
Sponsors:   Emory University;   Bristol-Myers Squibb;   The Cleveland Clinic;   Medical College of Wisconsin
Not yet recruiting

https://ift.tt/2IgguPz